A Study Comparing the Response of Patients With Hypertension to Amlodipine or Amlodipine Plus Benazepril.

• Status: Completed
• Trial end date: 2005-07-01
• Target enrollment: 0
• Participant gender: All

Summary

Comparison of the safety and efficacy of the combination of amlodipine/Benazepril to amlodipine monotherapy in patients with non-essential hypertension, not controlled on amlodipine alone.

• Phase: Phase 3

Details

• Lead Sponsor: Novartis
• Collaborator: Pfizer
• Treatments: Amlodipine; Benazepril

Criteria

Inclusion Criteria:

• Outpatients 18 years of age or older.

• Male or female patients are eligible. Female patients must be either post-menopausal for one year or surgically sterile, or using effective, contraceptive methods such as barrier method with spermicide, or an intrauterine device.

• Patients with essential hypertension as measured by a validated device

Exclusion Criteria:

• Severe hypertension (DBP > 115 mmHg diastolic and/or SBP > 180 mmHg systolic).

Other protocol-defined exclusion criteria may apply.